- ISIL creates all-female brigade to terrorize women into following Sharia law
- ISTOOK: Obama wants to be impeached
- Obama to Latin leaders: Help with border
- Military bans troops from Baptist church event honoring ‘God’s Rescue Squad’
- ‘Pocket drones’: U.S. Army developing tiny surveillance tools for the next big war
- Belgian cafe posts sign: Dogs allowed, but Jews stay out
- Gen. Dempsey: Pentagon studying Russian readiness plans not viewed ‘for 20 years’
- John McCain: Botched, two-hour execution of murderer is ‘torture’
- House GOP ready to move border bill
- Bomb squad called after live WWII artillery washes on Cape Cod beach
Second- and third-stringers eye 2016 if front-runner stumbles
Topic - Francis S. Collins
The National Institute of Health on Tuesday announced a partnership with a handful of major drug companies on a project to dramatically reduce the time it takes to create and market medications that treat debilitating diseases.
The federal government said Wednesday it will send 310 chimpanzees into early retirement because of new opinions on whether it's moral to use the prized primates for biomedical research.
"We are going to try to increase the odds of picking the right targets to go after for the next generations of drug developers," NIH Director Dr. Francis S. Collins said.
Dr. Collins said that too often drugs are found to be ineffective in the late stages of development — after years of work and millions of dollars in research and testing — because scientists chose the wrong biological targets.